Merger & Acquisition Services in Ahmedabad

Gujarat accounted for 30.7% of India’s total exports in 2024-25 — the highest of any state in the country (Economy of Gujarat, updated 2025). That figure sits on the back of a genuinely diversified industrial economy: chemicals, pharmaceuticals, textiles, gems and jewellery, engineering, petrochemicals, and now a fast-growing EV manufacturing corridor. Many of the businesses driving those numbers — promoter-run companies, family-owned manufacturers, first-generation chemical and pharma entrepreneurs — are now at inflection points. Succession, consolidation, PE investment, international buyers interested in India supply chains.

Ahmedabad is the commercial capital and largest industrial centre of western India outside Mumbai. The city’s metro GDP was estimated at US$136.1 billion in 2023, making it one of India’s economically significant urban centres. Home to Zydus Lifesciences, Torrent Pharmaceuticals, Arvind Mills, the Adani Group headquarters, and hundreds of mid-market manufacturers, Ahmedabad generates serious M&A deal flow across multiple sectors.

Sapient Services provides merger and acquisition advisory in Ahmedabad for pharma companies, chemical manufacturers, textile businesses, and mid-market family enterprises across Gujarat — buy-side, sell-side, and transaction structuring.

GIFT City and the Cross-Border M&A Angle

One factor that sets Ahmedabad apart from other Indian M&A markets: proximity to GIFT City (Gujarat International Finance Tec-City), India’s first operational International Financial Services Centre (IFSC), located 12 km from Ahmedabad on the Sabarmati River between Ahmedabad and Gandhinagar.

As of June 2025, GIFT City had 939 registered entities — including 47 insurance firms, 272 investment funds, and over 100 foreign companies. In 2025, GIFT City secured the top rank in reputational advantage in the Global Financial Centres Index (GFCI 37). Major law firms including Khaitan & Co opened dedicated GIFT City offices in 2025-26, citing growth in GCC structuring, cross-border investment platforms, M&A, and international debt capital markets as the primary drivers (Khaitan & Co press release, April 2026).

For Ahmedabad-based companies planning cross-border transactions or seeking offshore PE structures, GIFT City’s IFSC framework provides real advantages — tax exemptions including GST, dividend distribution tax, and capital gains tax for IFSC-registered entities. Sapient’s M&A advisory incorporates GIFT City structuring where relevant to the transaction.

What Drives M&A in Ahmedabad and Gujarat

Buy-Side and Sell-Side Advisory in Ahmedabad

Buy-Side: Finding the Right Acquisition Target in Gujarat

Buy-side work in Ahmedabad’s pharma and chemical sectors is often about regulatory standing, not just financial metrics. A buyer looking to acquire USFDA-approved manufacturing capacity, EU GMP certification, or WHO-GMP standing can’t build that in two years — it takes a decade of clean inspection history. Finding a target that has it, at a valuation the buyer can justify, is where structured advisory makes the real difference.

Sapient’s buy-side process starts with defining the acquisition criteria: specific certifications needed, technology capabilities, geography, and financial parameters. From there, structured target identification, confidential outreach under NDA, preliminary valuation, and due diligence coordination follow. The process ends at closing — not at term sheet.

Sell-Side: Taking an Ahmedabad Business to Market

Gujarat has a large cohort of promoters who built businesses from the 1980s through the 2000s. Many have no natural successor. The options — PE investment, strategic sale, partial divestiture — each carry different tax treatment, valuation implications, and governance consequences. Getting this decision right before engaging any external party is where Sapient’s pre-transaction advisory adds real value.

Sell-side preparation covers: financial documentation review (3-5 years audited accounts), regulatory compliance status, pending litigation assessment, GIDC industrial estate land title verification, key customer dependency analysis, and Information Memorandum preparation. The goal is a clean process that moves at pace — not a transaction that stalls because documentation wasn’t ready.

Valuation for Gujarat Companies

Pharma and chemical businesses are valued primarily on EV/EBITDA multiples against comparable Indian and international transactions, adjusted for regulatory standing. Companies with USFDA or EU GMP certification command significant premiums over those without. Textile manufacturers are typically valued on EBITDA plus asset base. Sapient’s valuers are IBBI-registered and produce reports accepted by banks, PE funds, and regulatory bodies.

Regulatory Checkpoints for Gujarat M&A

• CCI: Mandatory filing where individual assets exceed Rs 2,500 crore or turnover exceeds Rs 7,500 crore, or deal value exceeds Rs 2,000 crore with substantial India operations. Introduced September 2024 (Competition Act 2002, Section 6A). Most mid-market Gujarat deals fall below these thresholds.
• FEMA NDI Rules (August 2024 amendment): Foreign acquirers of Gujarat companies, and Indian companies acquiring abroad, use the updated framework. Share-for-share transactions between Indian and foreign companies are now specifically enabled.
• MCA / NCLT: Mergers via scheme of arrangement require NCLT approval under Companies Act 2013.
• GIDC / Industrial Estate: Land in GIDC-managed estates has specific transfer conditions. Share acquisitions generally don’t trigger land title transfer, but original allotment terms need review.
• IFSCA (GIFT City): For transactions where GIFT City structuring is used — relevant for cross-border deals, international PE, and offshore fund structures.

Questions from Ahmedabad Business Owners

Q-1: How is a Gujarat pharma company valued for a sale?

Revenue-generating pharma companies are valued on EV/EBITDA multiples — typically 8x to 16x depending on product mix, regulatory certifications, and R&D pipeline quality. Companies with active USFDA drug master files or EU approval command material premiums. Companies dependent on domestic generics trade at lower multiples. Asset-based valuation provides a floor for manufacturing-heavy businesses where earnings are depressed.

Q-2: What makes GIFT City relevant to an Ahmedabad M&A transaction?

GIFT City is India’s IFSC — it allows international PE funds, AIFs, and global investors to participate in Indian transactions through an offshore-equivalent structure with significant tax advantages. For Ahmedabad promoters looking to bring in international PE capital, a GIFT City-based fund structure can offer cleaner exit terms and better tax treatment than a direct onshore FDI investment. Sapient advises on when and how to use this structure.

Q-3: What is the China-plus-one effect on Gujarat chemical M&A?

Ans: Global chemical and pharma buyers seeking to reduce China supply chain dependency have been looking at India — and specifically Gujarat’s chemical belt — as an alternative. This has driven inbound acquisition interest from European and Japanese specialty chemical companies looking for Gujarat targets with established production and export track records. Sapient has seen this as an active deal driver for Ahmedabad and Vadodara companies since 2023.

Q-4: What does CCI’s new Deal Value Threshold mean for Gujarat transactions?

Ans: From September 2024, mandatory CCI filing is triggered where deal value exceeds Rs 2,000 crore and the target has substantial business operations in India — even if asset/turnover thresholds aren’t met (Competition Act 2002, Section 6A). For Gujarat, this is most relevant for large pharma acquisitions involving international buyers where deal consideration is high but the acquired company may have modest assets or turnover.

Q-5: Can multiple promoter families in a Gujarat business complicate a sale?

Ans: This is one of the most common reasons Gujarat family business transactions stall. All stakeholders — including family members holding minority stakes — must be aligned on exit price, structure, and timeline before any external buyer is approached. Once information leaks to the market, negotiating leverage erodes. Sapient’s pre-transaction work includes promoter alignment as a formal step before market engagement begins.

Q-6: How is due diligence done for a Gujarat chemical company?

Ans: Due diligence covers: audited financial statements (3-5 years), working capital analysis, GIDC land title and land use compliance, Pollution Control Board (GPCB) NOC and environmental clearances, REACH compliance for export-oriented companies, customer concentration analysis, and labour law status. For companies with USFDA or international regulatory certifications, the CE/GMP status and inspection history are central to the due diligence.

Q-7: What are the most active Gujarat M&A sectors heading into 2026?

Ans: Specialty chemical consolidation continues — global buyers from Europe and Japan are active for Gujarat targets with export capability. Pharmaceutical generics consolidation, particularly among second-tier manufacturers, is generating sell-side deal flow. In the EV supply chain, component manufacturers around Sanand are attracting investor attention as Suzuki, Honda, and JSW MG Motor scale Gujarat production. And first-generation MSME promoter exits are a steady deal category across all sectors.

Q-8: Does Sapient handle deals for companies based outside Ahmedabad — like Vadodara, Surat, or Rajkot?

Ans: Yes. Sapient’s Gujarat M&A practice covers the full state — including Vadodara’s chemicals and pharma cluster, Surat’s textile and diamond industries, Rajkot’s engineering and auto component manufacturers, and Ankleshwar/Vapi’s chemical manufacturing belt. The regulatory considerations and buyer profiles differ by sector and city, and Sapient’s advisory is structured accordingly.